Testing the Addition of the Drug Relugolix to the Usual Radiation Therapy for Advanced-Stage Prostate Cancer
Conditions: Oligometastatic Prostate Carcinoma; Prostate Adenocarcinoma; Stage IVB Prostate Cancer AJCC v8 Interventions: Drug: Placebo Administration; Other: Quality-of-Life Assessment; Drug: Relugolix; Radiation: Stereotactic Body Radiation Therapy Sponsors: NRG Oncology; National Cancer Institute (NCI) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Adenocarcinoma | Cancer | Cancer & Oncology | Carcinoma | Prostate Cancer | Radiation Therapy | Research